Hays Advisory’s Bristol-Myers Squibb BMY Stock Holding History

Hays Advisory’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,996	Closed	-$310K	–	8
2018 Q3	$310K	Buy	4,996 +352	+8%	+$20.9K	0.2%	53
2018 Q2	$257K	Buy	+4,644	New	+$251K	0.14%	55

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Hays Advisory's BMY Position: Q4 2018 in Review

Hays Advisory sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 4,996 shares — an estimated $310K sold.

Hays Advisory first reported a position in BMY in Q2 2018 and held it in 2 quarters. The position peaked at $310K in Q3 2018. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

Hays Advisory reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
Hays Advisory sold 4,996 Bristol-Myers Squibb shares in Q4 2018, an estimated $310K.
Hays Advisory first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 2 quarters.
Hays Advisory's Bristol-Myers Squibb position peaked at $310K in Q3 2018.
1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Hays Advisory's 13F filing for Q4 2018.